Gender differences in subjective discontinuation symptoms associated with ketamine use

Table 3 Subjective cognitive impairment and urinary tract symptoms among ketamine users and the adjusted odds ratios (AORs) between genders

		Total	Male	Female	AORs^c	P value	95% CI
Cognitive impairment	Nil	23.9%	24.7%	20.2%	reference	-	-
	mild	53.6%	53.9%	52.3%	1.275	0.258	0.837-1.942
	severe	22.4%	21.4%	27.5%	1.717	0.024*	1.075-2.741
Urinary tract symptoms	Nil	49.5%	49.7%	48.4%	reference	-	-
	mild^a	45.8%	46.5%	41.9%	0.915	0.601	0.656-1.276
	severe^b	4.8%	3.8%	9.7%	2.719	0.001**	1.501-4.928

^aIndicating symptoms as urgency/frequency occasionally but not usually.
^bIndicating symptoms as both pelvic pain and urgency/frequency, or one of the symptoms achieved usually or always, or having received clinical help.
^cThe reference category is Nil group in cognitive impairment and urinary tract symptoms respectively, after adjusted age.
P value: the risk of subjective cognitive impairment or urinary tract symptoms between genders 95% CI, 95% confidence intervals.
*p < 0.05, ** p< 0.01.

ISSN: 1747-597X